Skip to main navigation
  • Community
  • Science
    • Science Overview
    • MC4R Pathway
    • Our Research
    • Our Pipeline
    • Our Focus
    • Clinical Studies
    • Expanded Access
  • Careers
    • Life at Rhythm
    • Working at Rhythm
  • About
    • Senior Management
    • Board of Directors
  • Investor Relations
    • Overview
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • News
    • Contact IR
  • Contact Us
INVESTOR RELATIONS
  • Overview
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • News
  • Contact IR

News

January 5, 2021
Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M
RHYTHM

Contact Us

Rhythm Pharmaceuticals, Inc.
222 Berkeley Street, 12th Floor
Boston, MA 02116

COMMUNITY
SCIENCE
  • MC4R Pathway
  • Our Research
  • Our Pipeline
  • Our Focus
  • Clinical Studies
  • Expanded Access
  • Publications and Presentations
  • GOLD Academy
  • Glossary
CAREERS
  • Life at Rhythm
  • Working at Rhythm
ABOUT
  • Senior Management
  • Board of Directors
INVESTORS & MEDIA
  • Overview
  • Events and Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • News
  • Contact IR
© 2021 Rhythm Pharmaceuticals, Inc. All Rights Reserved.
Rhythm, GOLD Academy, LEAD for Rare Obesity, Uncommon Obesity, Uncovering Rare Obesity, and their corresponding logos are trademarks of Rhythm Pharmaceuticals, Inc.
Terms of Use Privacy Policy